Rebiotix Inc. (therapy likely RBX2660 / microbiota restoration therapy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rebiotix Inc. (therapy likely RBX2660 / microbiota restoration therapy), covering 2015-07-01 to 2015-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea [Phase 2]